Massimo Volpe

Pubblicazioni

Titolo Pubblicato in Anno
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension. one shot for a double strike? EUROPEAN HEART JOURNAL 2021
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke. the Uric Acid Right for Heart Health (URRAH) study JOURNAL OF HUMAN HYPERTENSION 2021
Long-term management of Takotsubo syndrome: a not-so-benign condition REVIEWS IN CARDIOVASCULAR MEDICINE 2021
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes EUROPEAN HEART JOURNAL 2021
Glycoprotein IIb/IIIa inhibitors may modulate the clinical benefit of radial access as compared to femoral access in primary percutaneous coronary intervention: a meta-regression and meta-analysis of randomized trials JOURNAL OF INTERVENTIONAL CARDIOLOGY 2021
Repurposing cardio-metabolic drugs to fight Covid19 HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
Role of induced pluripotent stem cells in diagnostic cardiology WORLD JOURNAL OF STEM CELLS 2021
Exploring RNA biomarkers in patients with acute myocarditis EUROPEAN HEART JOURNAL 2021
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile EUROPEAN HEART JOURNAL 2021
Worsening of risk factor control in US diabetic patients. a call to action EUROPEAN HEART JOURNAL 2021
A SPRINT towards tighter control of blood pressure in hypertension EUROPEAN HEART JOURNAL 2021
The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk EUROPEAN HEART JOURNAL 2021
Glycaemicindex. an emergent global silent killer for the heart EUROPEAN HEART JOURNAL 2021
Reply to the letter “Takotsubo syndrome: Any more covariates of its recurrence?” INTERNATIONAL JOURNAL OF CARDIOLOGY 2021
Coronavirus disease 2019 in patients with cardiovascular disease. clinical features and implications on cardiac biomarkers assessment JOURNAL OF CARDIOVASCULAR MEDICINE 2021
Unhealthy lifestyles mediate only a small proportion of the socioeconomic inequalities' impact on cardiovascular outcomes in US and UK adults. A call for action for social cardiology EUROPEAN HEART JOURNAL 2021
Vulnerable non-culprit coronary plaques. are they worth treating? EUROPEAN HEART JOURNAL 2021
A 'once-and-done' approach to the lifelong reduction of elevated cholesterol EUROPEAN HEART JOURNAL 2021
Are post-hoc analyses on subgroups sufficient to support new treatment algorithms of heart failure? The case of SGLT2 inhibitors associated with sacubitril/valsartan CARDIOLOGY 2021
An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation CELL DEATH & DISEASE 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma